🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ StockGenie AI

Elevance Health, Inc. ELV SPX

Healthcare · Healthcare Plans · United States
https://www.elevancehealth.com

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. The company also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, it provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is based in Indianapolis, Indiana.

READ MORE ›
$393.19
+4.62% 1Y

Market & Price

Market Cap
$85.39B
Current Price
$393.19
High / Low (52W)
$402.27 / $270.10
Beta
0.67

Valuation

Stock P/E
16.67
Industry PE
23.65
Forward P/E
13.44
PEG Ratio
1.44
Book Value
$201.97
Price to Book
1.95
P/S
0.43
EV/EBITDA
9.40
Dividend Yield
1.75%

Profitability & Returns

ROCE
-
ROE
12.09%
ROA
3.98%
Profit Margin
2.62%
Op Margin
5.30%
EPS (Latest Qtr)
$8.00
EPS (TTM)
$23.59

Balance Sheet & Liquidity

Debt/Equity
0.72
Quick Ratio
1.33
Current Ratio
1.48
Debt
$31.84B
Total Assets
$121.49B
Current Assets
-
Working Capital
-

Ownership

Promoter Holding
0.19%
Chg in Prom Hold
-
FII / Inst Holding
93.38%
Chg in FII Hold
-0.01%

Financial Snapshot

Enterprise Value
$80.30B
Total Revenue (TTM)
$200.42B
EBITDA
$8.54B
Free Cash Flow
$4.30B
Operating Cash Flow
$7.61B
Shares Outstanding
217.16M
Gross Margin
25.89%
Payout Ratio
29.03%

Growth (CAGR)

Revenue 5Y
8.34%
Profit 5Y
-1.33%
Revenue (YoY)
2.60%
Earnings (YoY)
-16.80%

PROS

  • Generates positive free cash flow.
  • In a confirmed uptrend (50-DMA above 200-DMA).

CONS

  • Earnings shrank at -1.3% CAGR over 5 years.

* The pros and cons are auto-generated from financial metrics.

Price Chart

Robinhood TradingView StockAnalysis

Fundamental Growth

Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).

Peer comparison

Peer companies in the same sector (Healthcare).

#NameCMP $P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 ELV Elevance Health, Inc. SPX 393.19 16.67 $85.39B 1.75% - 12.09% 8.34% -1.33%
2 LLY Eli Lilly and Company SPX 1,105.00 39.21 $985.37B 0.63% 38.44% 107.46% 31.69% 48.96%
3 JNJ Johnson & Johnson SPX 225.33 26.11 $542.42B 2.38% 23.13% 26.42% 5.60% 14.32%
4 UNH UnitedHealth Group Incorporated SPX 380.31 28.66 $345.38B 2.32% 9.60% 12.18% 11.35% -15.69%
5 MRK Merck & Co., Inc. SPX 118.72 33.44 $293.22B 2.86% 20.66% 18.94% 3.12% 7.93%
6 TMO Thermo Fisher Scientific Inc. SPX 492.51 27.11 $183.03B 0.38% 9.17% 13.52% -0.27% -1.19%
7 AMGN Amgen Inc. NDXSPX 336.79 23.42 $181.77B 2.99% 18.02% 101.32% 11.77% 5.58%
8 GILD Gilead Sciences, Inc. NDXSPX 134.43 18.29 $166.90B 2.44% 22.92% 43.36% 2.57% 22.83%
9 ISRG Intuitive Surgical, Inc. NDXSPXAI 424.64 51.53 $150.39B - 15.96% 17.23% 17.39% 29.26%
Ad space

Quarterly Results

Figures in USD.

Metric Sep 2015Dec 2015Mar 2016Jun 2016Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020Jun 2020Sep 2020Dec 2020Mar 2021Jun 2021Sep 2021Mar 2022Jun 2022Sep 2022Mar 2023Jun 2023Sep 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue 19.90B20.19B20.29B21.46B21.40B21.71B22.52B22.41B22.43B22.68B22.54B22.94B23.25B23.37B24.67B25.47B26.67B27.41B29.62B29.26B31.16B31.82B32.38B33.85B35.82B38.09B38.63B39.94B42.17B43.67B42.85B42.58B43.89B--48.89B49.78B50.71B49.75B50.18B
Cost of Revenue ----------------------------------------
Gross Profit ----------------------------------------
Operating Expenses ----------------------------------------
Operating Income 1.22B-1.57B1.50B1.08B-1.59B1.23B982.00M-1.87B1.56B1.25B-1.94B1.43B1.53B-2.19B3.36B201.00M-2.16B2.08B2.06B2.43B2.35B2.25B2.83B2.63B1.76B3.02B2.77B--3.14B2.63B1.76B581.00M2.66B
EBITDA ----------------------------------------
Interest Expense -----------------------------------344.00M341.00M351.00M366.00M357.00M
Pretax Income -----------------------------------2.80B2.29B1.41B215.00M2.30B
Tax Provision -----------------------------------613.00M548.00M219.00M-331.00M544.00M
Net Income 654.80M180.90M703.00M780.60M617.80M368.40M1.01B855.00M747.00M1.23B1.31B1.05B960.00M424.00M1.55B1.14B1.18B934.00M1.52B2.28B222.00M551.00M1.67B1.79B1.51B1.79B1.64B1.60B1.99B1.85B1.29B2.25B2.30B--2.18B1.74B1.19B547.00M1.76B
Diluted EPS 2.430.682.632.912.301.373.733.162.804.674.993.983.621.615.914.364.553.625.948.910.872.196.717.256.137.326.736.628.307.795.459.599.85--9.617.725.322.478.00

Profit & Loss (Annual)

Figures in USD.

Metric Dec 2007Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue 61.17B61.25B64.94B58.70B60.71B61.50B71.02B73.87B79.16B84.86B90.04B92.11B104.21B121.87B-156.59B171.34B176.81B199.12B
Cost of Revenue -------------------
Gross Profit -------------------
Operating Expenses -------------------
Operating Income -4.35B4.18B4.08B3.78B3.62B4.00B4.42B4.75B4.80B4.17B5.43B6.00B6.36B-8.45B8.74B9.09B8.11B
EBITDA -------------------
Interest Expense ---------------851.00M1.03B1.19B1.40B
Pretax Income ---------------7.60B7.71B7.90B6.71B
Tax Provision ---------------1.71B1.72B1.93B1.05B
Net Income 3.35B2.49B4.75B2.89B2.65B2.66B2.49B2.57B2.56B2.47B3.84B3.75B4.81B4.57B-5.89B5.99B5.98B5.66B
Diluted EPS 5.564.769.886.947.258.188.208.999.389.2114.3514.1918.4717.98-24.8125.2225.6825.21

Compounded Sales Growth

5 Years:8.34%
1 Year:2.60%

Compounded Profit Growth

5 Years:-1.33%
1 Year:-16.80%

Stock Price Performance

1 Year:+4.62%
6 Months:+18.25%
3 Months:+23.63%
1 Month:+4.40%

Balance Sheet (Annual)

Figures in USD.

Metric Dec 2006Dec 2007Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Total Assets --48.40B52.13B50.17B52.16B58.96B59.57B61.68B61.72B65.08B70.54B71.57B77.45B86.61B97.46B102.75B108.93B116.89B121.49B
Current Assets --------------------
Cash & Equivalents 2.60B2.77B2.18B4.82B1.79B2.20B2.48B1.58B2.15B2.11B4.08B3.61B3.93B4.94B5.74B4.88B7.39B6.53B8.29B9.49B
Inventory --------------------
Receivables ----------------7.08B7.90B8.01B10.07B
Total Liabilities --26.97B27.26B26.35B28.88B35.15B34.81B37.42B38.67B39.98B44.04B43.03B45.73B53.42B61.33B66.42B69.52B75.46B77.47B
Current Liabilities --15.02B14.67B14.01B15.90B15.99B16.35B18.75B19.09B21.29B23.36B21.96B23.53B29.45B34.88B----
Long Term Debt --7.83B8.34B8.15B8.47B14.17B13.57B14.02B15.32B14.36B17.38B17.22B17.79B19.34B21.16B22.35B23.25B29.22B30.80B
Total Debt ----------------24.11B25.12B31.23B32.05B
Total Equity 24.58B22.99B21.43B24.86B23.81B23.29B23.80B24.77B24.25B23.05B25.10B26.50B28.54B31.73B33.20B36.06B36.24B39.31B41.31B43.88B
Shares Outstanding ----------------237.96M233.07M227.48M220.72M

Cash Flows (Annual)

Figures in USD.

Metric Dec 2007Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating Cash Flow 4.34B2.54B3.04B1.42B3.37B2.74B3.05B3.37B4.21B3.27B4.18B3.83B6.06B10.69B-8.40B8.06B5.81B4.29B
Investing Cash Flow -768.90M616.20M3.00B-1.27B-942.00M-4.55B-2.23B-974.90M-1.15B-514.00M-5.08B-1.26B-2.79B-7.32B--4.56B-5.57B-5.17B-1.34B
Financing Cash Flow -3.41B-3.74B-3.40B-3.17B-2.02B2.09B-1.72B-1.82B-3.09B-799.00M427.00M-2.24B-2.27B-2.57B--1.32B-3.35B1.19B-1.74B
Capital Expenditure -322.00M-345.60M-378.40M-451.40M-519.50M-544.90M-646.50M-714.60M-638.20M-584.00M-791.00M-1.21B-1.08B-1.02B--1.15B-1.30B-1.26B-1.12B
Free Cash Flow 4.02B2.19B2.66B965.30M2.85B2.20B2.41B2.65B3.57B2.69B3.39B2.62B4.98B9.67B-7.25B6.76B4.55B3.17B
Net Change in Cash ---------------2.52B-860.00M1.83B1.21B
Share Buybacks 6.15B3.28B2.64B4.36B3.04B2.50B1.62B3.00B1.52B02.00B1.69B1.70B2.70B1.90B2.32B2.68B2.90B2.60B
Dividends Paid ---0357.80M367.10M448.00M480.70M656.60M684.00M705.00M776.00M818.00M954.00M1.10B1.23B1.40B1.51B1.53B

Ratios (Annual)

Figures in %.

Metric Dec 2007Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Gross Margin % -------------------
Operating Margin % -7.1%6.4%6.9%6.2%5.9%5.6%6.0%6.0%5.7%4.6%5.9%5.8%5.2%-5.4%5.1%5.1%4.1%
Net Margin % 5.5%4.1%7.3%4.9%4.4%4.3%3.5%3.5%3.2%2.9%4.3%4.1%4.6%3.8%-3.8%3.5%3.4%2.8%
ROE % 14.6%11.6%19.1%12.1%11.4%11.2%10.1%10.6%11.1%9.8%14.5%13.1%15.2%13.8%-16.3%15.2%14.5%12.9%
ROCE % -13.0%11.2%11.3%10.4%8.4%9.3%10.3%11.2%11.0%8.8%10.9%11.1%11.1%-----

Shareholding Pattern

Insiders
0.19%
Institutions
93.38%
Public Float
93.56%

Top Institutional Holders

#Holder% HeldSharesValue
1 Blackrock Inc. 9.16% 19.89M $7.82B
2 Vanguard Capital Management LLC 6.61% 14.35M $5.64B
3 State Street Corporation 4.74% 10.29M $4.05B
4 Wellington Management Group, LLP 3.79% 8.23M $3.24B
5 Vanguard Portfolio Management LLC 2.93% 6.36M $2.50B
6 Sanders Capital, LLC 2.71% 5.89M $2.32B
7 Geode Capital Management, LLC 2.39% 5.19M $2.04B
8 Artisan Partners Limited Partnership 2.36% 5.13M $2.02B
9 Invesco Ltd. 2.22% 4.82M $1.89B
10 Harris Associates L.P. 2.21% 4.80M $1.89B

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for ELV

No recent headlines available.

Explore More

📊 Healthcare Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks